title: Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
authors.affiliation: Shanghai Institute of Hematology, Shanghai Second Medical University, People's Republic of China.
authors.forename: M E
authors.initials: ME
authors.lastname: Huang
authors.forename: Y C
authors.initials: YC
authors.lastname: Ye
authors.forename: S R
authors.initials: SR
authors.lastname: Chen
authors.forename: J R
authors.initials: JR
authors.lastname: Chai
authors.forename: J X
authors.initials: JX
authors.lastname: Lu
authors.forename: L
authors.initials: L
authors.lastname: Zhao
authors.forename: L J
authors.initials: LJ
authors.lastname: Gu
authors.forename: Z Y
authors.initials: ZY
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced / Q000453:epidemiology; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012074:Remission Induction; D013237:Stereoisomerism; D014212:Tretinoin / Q000009:adverse effects / Q000627:therapeutic use*; D014410:Tumor Stem Cell Assay
chemical_list: D014212:Tretinoin